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Although a key function of cancer genetics services is to provide risk information, to date there has been little consistency in the way
in which breast cancer risk perception has been measured. The aims of the study were to measure estimates of (i) population risk, (ii)
absolute risk and (iii) comparative risk of developing breast cancer for Ashkenazi Jewish women, and to determine predictors of
breast cancer risk perception. Of 152 women, 107 (70%) completed all questions. The mean (s.d.) estimates for population
risk, absolute risk and comparative risk were 22.7% (15.9), 31.8% (20.6) and 1.9-fold (1.9), respectively. Most women over-
estimated population risk. Women at population risk generally overestimated the population risk and their own absolute risk, yet
understood they are at the same risk as the population. Those with a family history understood that they are at increased risk, but
underestimated the extent to which their familial risk is increased. Anxiety, high estimation of population risk and lesser family history
predicted overestimation of absolute risk, whereas high estimation of population risk and a strong family history predicted
underestimation of comparative risk.
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A key function of cancer genetics services is to provide clients with
cancer and genetic risk information, for the purpose of informing
clients, aiding decision-making, reducing anxiety and possibly
improving adherence to appropriate screening practices. In the
context of breast cancer, this includes discussion of both the
woman’s risk of developing breast cancer and of the major factors
contributing to this risk, in particular her family cancer history.
These services may further try to identify clients’ misconceptions
about breast cancer risk and modify their beliefs so as to provide
clients with a more realistic view of their own breast cancer risk.
An accurate and reliable measure of women’s breast cancer
perception is required to assess whether women accurately
estimate their breast cancer risk before genetic counselling, and
if not, to assess to what extent cancer genetics services are
successful in modifying inaccurate breast cancer risk perceptions.
However, after more than a decade of literature, there is little
consensus on how risk perception should be measured.
It has previously been recognised that risk perception measure-
ment may depend on both the statistical measure and the
population studied (Dupont and Plummer, 1996). Risk perception
has been measured both as an absolute risk and as a comparative
risk, and using a range of reference times, so there are a variety of
ways of presenting risk. A common way of measuring absolute risk
has been to ask: ‘what do you think is your chance of getting breast
cancer’. A common way of measuring comparative risk has been to
ask: ‘what do you think is your chance of getting breast cancer
compared toy’, with comparison usually made to women in the
general population either specified to be of the same age as the
individual, or with no age specification. Time frames that have
been used for these questions include ‘in the next 5 years’, ‘in
the next 10 years’, ‘to age 70’, ‘to age 80’ or ‘in your lifetime’.
Responses have been presented in categories (e.g., ‘high’,
‘moderate’ or ‘low’) or as continuous variables, usually as ratios
or percentages (Watson et al, 1999; Hopwood et al, 2003; Schapira
et al, 2004; Gurmankin Levy et al, 2006; Zajac et al, 2006).
With regard to the population studied, if estimates are pooled
for women of differing actual risk categories (e.g., across the
spectrum of family histories), important issues may be masked.
This is because risk perception and its determinants may differ by
actual risk. More recent publications have compared, rather than
pooled, women from different absolute risk categories or limited
their study to women from a specific absolute risk category
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s(Hopwood et al, 2003; van Dooren et al, 2004; Haas et al, 2005;
Edwards et al, 2006).
Another concept not often studied in the context of risk
perception for breast cancer is that of an anchor point. There is an
extensive literature examining perceptions of risk in the context of
transportation safety and environmental hazards (Lichtenstein
et al, 1978; Slovic 1987; Hakes and Viscusi, 2004; Andersson and
Lundborg, 2007). This literature provides significant evidence to
support the notion that people determine their risk of a given
event by using a reference (anchor) point and they better estimate
their absolute risk of a given event if they are first provided with an
accurate reference risk. This suggests that people may think well in
terms of comparative risk and it may be possible to alter absolute
risk perceptions by including counselling about the reference risk.
To our knowledge, the study by Dillard et al (2006) is the only
study to date that has examined anchor points in the context of
breast cancer risk perception.
In this study, we asked Ashkenazi Jewish women participating
in a study of the breast cancer susceptibility genes BRCA1 and
BRCA2 their perceptions of: (i) the population risk of breast
cancer, (ii) their absolute risk of breast cancer and (iii) their
comparative risk of breast cancer to determine predictors of breast
cancer risk perception as a function of women’s family histories
and their actual absolute and comparative risks.
MATERIALS AND METHODS
The study was approved by the Human Research Ethics
Committees of the Peter MacCallum Cancer Institute (Melbourne),
The Prince of Wales Hospital (Sydney) and The University of
Melbourne. Written informed consent was obtained from all
participants.
Subjects
Participants of the Australian Jewish Breast Cancer Study (AJBCS)
were self-identified as being of Ashkenazi Jewish descent, living in
Melbourne or Sydney, and reported having (a) had an earlier
diagnosis of breast or ovarian cancer themselves or (b) a first- or
second-degree male or female relative who had been diagnosed
with breast or ovarian cancer (Apicella et al, 2006). They were
recruited through announcements in the media (local Jewish
newspapers (32%) and other newspapers (3%)), approaches
including brochures to general practitioners, gynaecologists, breast
surgeons and oncologists (19%), the family cancer genetics clinics
associated with this study (9%), information evenings (11%) and
friends or relatives (26%).
Eligible subjects for this study were participants of the AJBCS
without breast cancer or prophylactic bilateral mastectomy; with
complete personal characteristics and family cancer history data;
and who returned a follow-up questionnaire with all risk questions
completed.
Baseline data collection
At recruitment into the AJBCS, demographic data and information
on personal and family cancer history were collected. Blood
samples were taken and genetic testing performed for the
mutations 185delAG and 5382insC in BRCA1 and 6174delT in
BRCA2 (Apicella et al, 2006).
Follow-up questionnaire
A follow-up questionnaire was mailed to all AJBCS participants on
an average of 44 months (7–60 months) after their enrolment. For
women who learnt their genetic test result, an average of 39
months (5–57 months) had elapsed since their attendance at a
cancer family genetics clinic. The follow-up questionnaire included
a genetic knowledge instrument consisting of nine true–false
questions. This instrument was developed specifically for know-
ledge about breast cancer and the BRCA1 and BRCA2 genes
(Hughes et al, 1997; Lerman et al, 1997). Participants were also
asked about recent life events, including whether a close relative
had recently died, or was recently diagnosed with cancer. The State
Trait Anxiety Inventory (STAI) Y2 version was administered
(Spielberger, 1983).
Questions on risk perception
The follow-up questionnaire included questions on risk perception
that were developed for this study. These questions asked
participants to (1) Provide a numeric value for their perception
of population risk; ‘What percentage (number from 0 to 100) of
women in the population do you think will get breast cancer in
their lifetime?’ (2) Choose an option to describe their comparative
risk. ‘Do you think YOUR chance of getting breast cancer is higher
or lower than this, or about the same? Please tick the box to
indicate your response’ (options: no risk; much lower; a little
lower; same; a little higher; much higher; definitely will get breast
cancer) (3) Provide a numeric value for their perception of their
own absolute risk of developing breast cancer. ‘In your opinion,
what percentage (number from 0 to 100) reflects your chance of
getting breast cancer in the future?’
The participants’ numeric value for their perception of their
comparative risk was then derived by dividing their perception of
their absolute risk by their perception of the population risk. For
example, a woman who responded that the population risk was
25%, and her absolute risk was 50%, would have a numeric
perceived comparative risk of 50/25¼2.0.
Genetic information and risk counselling
Participants received a genetic information session at the time of
enrolment. Those who wished to receive their genetic test result
also attended a cancer family genetics clinic to receive further
genetic counselling and later attended a genetics clinic for a result
disclosure appointment. The genetic information sessions were
conducted by the researchers and the clinic appointments were
conducted by 14 genetic counsellors and clinic geneticists, based at
six clinics. Risk counselling was provided during the genetic
information session and at each of the clinic appointments, so that
all participants in this study received risk counselling on at least
one occasion and most received it on at least two or three
occasions.
The risk counselling provided to participants included discus-
sion of the population risk of getting breast cancer and of the
participant’s absolute and comparative risk of developing breast
cancer. The NBCC guide for health professionals on familial
aspects of breast and ovarian cancer is used by Australian breast
cancer family genetics clinics. Information on their category and
the estimated absolute and comparative risk ranges were provided
to participants at both the genetic information session and the
genetic counselling appointment(s) using the guide (National
Breast Cancer Centre, 2006). That is, women were counselled using
this guide by showing them the categories and explaining which
risk category they belonged to and the associated absolute and
comparative risk range. In addition to the guide, some genetic
counsellors also presented breast cancer risks in other ways. The
extent, content or techniques used by counsellors for additional
risk counselling were not recorded.
Actual risk and coding the participants’ risk estimates
For this study, we used the risk figures provided by the researchers
and genetic counsellors to the participants as estimates of the
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sactual risk. For population risk, participants were told the figure of
a 9% lifetime risk, and so responses within a range of 7–12% were
coded as ‘correct’. Participants who estimated the population risk
to be above 12% were coded as having overestimated, and those
selecting less than 7% were coded as having underestimated.
Given that all participants were counselled with estimates
of their absolute risk and comparative risk of developing
breast cancer determined from the NBCC guide, we used the
categories of the guide as an estimate of the participant’s
actual risk. The family history categories are: Family History
Category 1, 2 and 3. Individuals in Family History Category 1 are
those at population risk of developing breast cancer, and women
in this category were informed that they were at the same risk
as the general population, which is 9%. Responses in the range
of 7–12% were therefore coded as correct (as for the estimate of
the population risk), corresponding to a comparative risk of
0.8- to 1.3-fold. Participants in Family History Category 2 and 3 are
those at estimated risks (as per NBCC guide) of 13–25% and
26–49%, respectively, corresponding to comparative risks of
1.4- to 2.8-fold and 2.9- to 5.4-fold, respectively. Participants’
estimates of their own absolute risk, and the calculated compara-
tive risk, were coded as having being estimated correctly if they
were within the stated ranges; overestimated if above the upper
limit of those ranges; and underestimated if below the lower limit
of those ranges.
In addition, a number of women in this study learnt that they
carry an ancestral mutation in BRCA1 or BRCA2. These women
were provided with different risk information from those who did
not carry these mutations. Available data on the penetrance of
these mutations changed over the course of this study, and so
women who received their results in 1996 or early in 1997 were
counselled that a mutation conferred an 85–90% risk of
developing breast cancer, whereas those who received their result
later were counselled that this conferred a risk of ‘about 50%’. For
mutation carriers, we therefore coded any responses for absolute
risk between 50 and 90% and comparative risk between 5.5- and
10-fold as having been estimated correctly; those above these
ranges were coded as having overestimated; and those below these
ranges were coded as having underestimated.
For the question asking women to select a response that best
describes their comparative risk in words, women in any family
history category who selected ‘a little lower’ or ‘much lower’ were
coded as underestimated.
Those in Family History Category 1 who selected ‘same’ were
coded as correctly estimated, and those who selected ‘a little
higher’ or ‘much higher’ were coded as overestimated.
Those in Family History Category 2 who selected ‘same’ were
coded as underestimated, those who selected ‘a little higher’ as
correctly estimated and those who selected ‘much higher’ were
coded as overestimated.
Those in either Family History Category 3 or the Mutation
Carrier Category who selected ‘same’ or ‘a little higher’ were coded
as underestimated, and those who selected ‘much higher’ were
coded as correctly estimated. For these two categories, a woman
was only coded as overestimated if she selected ‘definitely will get
breast cancer’.
Statistical analysis
Regression analysis was performed to identify predictors of
women’s risk estimates. Five analyses were conducted with the
dependent variables on the log odds of women’s estimates of:
(i) population risk, (ii) absolute risk, (iii) comparative risk,
(iv) overestimation of absolute risk and (v) underestimation of
comparative risk. Independent variables were indicators of
respondents’ personal characteristics. Analyses were preformed
using Stata v8.2.
RESULTS
Of the 339 AJBCS participants who were sent the follow-up
questionnaire (average 44 months after enrolment in the study),
256 (76%) returned them. However, 100 women with breast cancer
and 4 unaffected women who had had prophylactic bilateral
mastectomy were excluded. Of the remaining 152 women eligible
for this study, 109 (72%), 144 (95%) and 128 (84%) gave a response
for the numeric estimate of population risk of breast cancer, their
own absolute risk of developing breast cancer and their
comparative risk of developing breast cancer, respectively.
Complete personal characteristic data, family cancer history data
and risk question data were available for 107 participants (70%).
Table 1 describes the personal characteristics of 107 full
respondents. The majority were aged between 25 and 54 years,
and were parous. About half held a university degree and the mean
Table 1 Descriptive table
Personal characteristics N Percent
Age (N¼107)
25–54 years 74 69
55–74 years 32 30
75 years + 1 1
Mean (s.d.) 49.4 (10.3)
Number of children (N¼102)
02 1 2 1
19 9
2 or 3 65 64
4 or more 7 7
Mean (s.d.) 1.9 (1.7)
University degree (N¼107)
Yes 62 42
No 45 58
Actual risk of developing breast cancer (N¼106)
Family History Category 1 (AR 7–12%) 43 41
Family History Category 2 (AR 13–25%) 29 27
Family History Category 3 (AR 26–49%) 25 24
Carrier of ancestral mutation (AR 50–90%) 9 8
Genetic knowledge (max 9) (N¼107)
1–3 (poor) 3 3
4–6 (fair) 25 23
7–9 (good) 79 74
Mean (s.d.) 7.1 (1.5)
Anxiety (STAI Trait) (N¼104)
o40 64 62
40–54 33 32
55–70 7 7
Mean (s.d.) 37.7 (1.5)
Recent death of a relative (N¼105)
Yes 21 20
No 84 80
Recent cancer of a relative (N¼103)
Yes 22 21
No 81 79
Attended genetic clinic (N¼107)
Yes 95 89
No 12 11
Received genetic test result (N¼107)
Yes 88 82
No 19 18
AR¼absolute risk.
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children (Po0.05), whereas younger women were more likely to
have a university degree (Po0.01) and had better genetic
knowledge (Po0.05). The mean STAI score was 37.7 (1.5). Recent
cancer diagnosis in the family was associated with being a carrier
of an ancestral mutation (Po0.01).
Table 1 further shows that 95 of the 107 full respondents
attended a genetics clinic appointment and that 88 received their
genetic test result. That is, all participants received the risk
counselling at least once (as part of the genetic information session
delivered at enrolment); 95 women received it on at least two
separate occasions (the genetic information session and genetic
clinic appointment); and 88 women received it on three separate
occasions (the genetic information session, genetic clinic appoint-
ment and genetic clinic result disclosure appointment).
Table 2 shows participants’ responses to the risk questions.
The mean (s.d.) estimate for the population risk was 22.7% (15.9)
and was similar across all family history categories. More than half
overestimated population risk (estimations 412%), whereas only
5% underestimated (estimations o6%). The mean (s.d.) estimate
for their own absolute risk was 31.8% (20.6) and increased
with family history, ranging from 22.7% for those in Family
History Category 1 to 45% for mutation carriers. Overall, about
half overestimated absolute risk. The mean (s.d.) estimate for
comparative risk was 1.9-fold (1.9) and increased with family
history, ranging from 1.2-fold for those in Family History Category
1 to 3.0-fold for mutation carriers. Almost half of all women
underestimated their comparative risk of developing breast cancer,
whereas the three-fourth of women at actual comparative risk
42.8 (i.e., Family History Category 3 and mutation carriers)
underestimated their comparative risk.
From Table 2, it can be seen that overall the proportion who
underestimated their comparative risk in words was 46%
compared with 48% who underestimated the numeric comparative
risk. Similarly, 40 (65%) above population risk underestimated
their comparative risk in words and 40 (65%) above population
risk underestimated their numeric comparative risk.
Multivariate regression was performed on the log odds of
participants’ estimates of population risk, their own absolute risk
and their calculated comparative risk (their estimate of their own
absolute risk divided by their estimate of the comparative risk).
Results are reported in Table 3 for the women who provided
complete responses for all risk questions, and for whom all
personal characteristic data were available.
Genetic knowledge and anxiety scores were significantly
associated with estimated population risk. An increase in genetic
knowledge score was significantly associated with a decrease in
the estimate of the population risk, whereas an increase in anxiety
score was significantly associated with an increase in estimate of
the population risk.
Genetic knowledge score was significantly associated with an
increase in the estimated absolute risk. Further, having a strong
family cancer history (Family History Category 3) and being a
mutation carrier (Family History Category Carrier) were also
significantly associated with an increase in the estimated absolute
risk. There were no statistically significant independent associa-
tions between genetic knowledge scores and family history.
Family history and mutation carrier status were significantly
associated with increasing estimates of comparative risk. That is,
having a moderate (Family History Category 2) or strong (Family
History Category 3) family cancer history and being a mutation
carrier (Family History Category Carrier) were associated with
higher estimates of their comparative risk compared with women
at population risk (Family History Category 1).
Finally, regression analysis was used to identify predictors of
overestimation of absolute risk and predictors of underestimation
of comparative risk (see Table 4). Those with a recent death in the
family were less likely to overestimate their absolute risk, whereas
higher anxiety scores were associated with greater overestimation.
A higher estimate of the population risk and a lower family history
Table 2 RR, absolute and population risk by family history
Family History
Category 1; RR 0.8–1.3;
AR 7–12% (n¼40)
Family History
Category 2; RR 1.4–2.8;
AR 13–25% (n¼29)
Family History
Category 3; RR 2.9–5.4;
AR 26–49% (n¼24)
Mutation carriers;
RR 5.5–10.0;
AR 50–90% (n¼9)
Total
(N¼102)
Population risk
Mean estimate (s.d.) 21.3 (16.4) 24.1 (15.4) 25 (16.8) 18.4 (13.6) 22.7 (15.9)
Overestimating 18 (45) 19 (66) 15 (63) 4 (44) 56 (55)
Correct 21 (53) 9 (31) 6 (25) 5 (56) 41 (40)
Underestimating 1 (3) 1 (3) 3 (13) 0 (0) 5 (5)
Absolute risk
Mean estimate (s.d.) 22.7 (18.1) 31.8 (16.9) 42 (21.4) 45 (23.2) 31.8 (20.6)
Overestimating 22 (55) 16 (55) 12 (50) 0 (0) 50 (49)
Correct 11 (28) 10 (34) 5 (21) 6 (67) 32 (31)
Underestimating 7 (18) 3 (10) 7 (29) 3 (33) 20 (20)
Calculated comparative risk (estimated own absolute risk/estimated population risk)
Mean estimate (s.d.) 1.2 (0.8) 1.6 (0.9) 2.9 (3.2) 3.0 (1.8) 1.9 (1.9)
Overestimating 8 (20) 5 (17) 4 (17) 0 (0) 17 (17)
Correct 23 (58) 9 (31) 3 (13) 1(11) 36 (35)
Underestimating 9 (23) 15 (52) 17 (71) 8 (89) 49 (48)
Comparative risk in words
Overestimating 6 (15) 1 (3) 0 (0)* 0 (0)* 7 (7)
Correct 27 (68) 11 (38) 6 (25) 4 (44) 48 (47)
Underestimating 7 (18) 17 (59) 18 (75) 5 (66) 47 (46)
AR¼absolute risk; RR¼relative risk.
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scategory were also associated with a greater overestimation of
absolute risk.
The only variables significantly associated with underestimation
of comparative risk were the estimates of population risk and the
family history category variables. Higher estimates of population
risk and higher family history category (i.e., higher actual
comparative risk) were associated with greater underestimation
of comparative risk.
DISCUSSION
In this study, we used a novel approach to determine Ashkenazi
Jewish women’s estimates of their risk of developing breast cancer.
Women were asked their numeric estimates of the population risk
and their own absolute risk of developing breast cancer. Their
responses were used to calculate their numeric estimate of their
comparative risk of developing breast cancer. Further, a compara-
tive risk question, asking the women to choose a category that
describes their comparative risk in words, was included to
determine whether the numeric values provided by the women
reflected their understanding.
We have shown that the response in words selected by these
women to describe their comparative risk of developing breast
cancer was remarkably consistent with the numeric comparative risk
calculated by dividing their percentage estimate of the population
risk with their percentage estimate of their own absolute risk.
We have further shown that women’s estimates of the
population risk were far higher than the actual population risk
of 9%. Overall, participants estimated that more than one in five
Australian women will develop breast cancer, when in reality less
than half that number will be diagnosed with the disease in their
lifetime. Although higher anxiety scores and lower genetic
knowledge scores were associated with higher estimates of
population risk, the variables included in regression analysis
accounted for only a small amount of variation in the data. That is,
the number selected for the population risk was for the most part
random. This finding is consistent with the economics and
psychology literature on risk perception, and suggests that the
population risk estimate may be an anchor point upon which other
estimates are made (Slovic et al, 1981).
For most women, their estimated absolute risk was far higher than
their actual absolute risk. The regression model for absolute risk
showed that the absolute risk estimate was significantly associated
with family history category. This suggests that, in general, women in
this study have understood that their family history is associated
with an increased risk of developing breast cancer.
The regression model for comparative risk showed that
increasing family history category was associated with a higher
estimate. This is further evidence that these women understood
that a family history is associated with their own risk of developing
the disease. In contrast, the regression of underestimation of
comparative risk showed that there was greater underestimation
with increasing family history category. This, in combination with
the finding that 79% of women in Family History Category 3 and
89% of mutation carriers underestimated their comparative risk,
suggests that women may not have understood the extent to which
their family history of breast cancer increased their risk of disease.
This could, however, also have been due to a ‘ceiling effect’. For
women in the highest family history categories to have obtained a
correct comparative risk, they would need to have estimated
extremely high values for their own absolute risk (near 100% or
greater), given their high estimate for the population risk. There is
a possibility, therefore, that the underestimation of comparative
risk in these women could be because they have reached a ceiling
or upper limit.
The economics of safety literature provides some insight into
this issue. Data have been collected where one half of the study
participants were asked to estimate the risk of three events (e.g.,
death in a car crash, motorcycle crash and bus crash), and the
other half were provided with the actual risk figure for the first
event (death in a car crash) and asked to estimate the risk of the
second and third events (death in a motorcycle and bus crash).
This study showed that in the first instance all three scenarios were
highly overestimated, but once an anchor point had been placed
for the first, the estimate of the second and third scenario came
much closer to the actual absolute risk and also much closer to the
actual comparative risk (Philips et al, 1989).
In the context of women in the higher family history categories,
therefore, it would be of interest to ask their estimates of their
absolute risk when the question is repeated after provision of the
actual population risk. If the absolute risk estimate does not alter
Table 3 Predictors of population risk, absolute risk and RR
Log odds of the estimate of
population risk
Log odds of the estimate of
absolute risk
Log odds of the estimate of
comparative risk
Number of obs¼96 Number of obs¼94 Number of obs¼70
R
2¼0.28 R
2¼0.52 R
2¼0.74
Independent variables Coefficient
a 95% CI P-value Coefficient
a 95% CI P-value Coefficient
a 95% CI P-value
Age  0.02  0.04–0.00 0.12 0.00  0.02–0.02 0.87 0.01  0.03–0.05 0.55
University degree  0.25  0.67–0.17 0.25 0.11  0.28–0.50 0.58  0.01  0.71–0.69 0.97
Parity 0.12  0.03–0.26 0.12 0.04  0.10–0.18 0.55  0.01  0.25–0.24 0.95
Genetic knowledge score  0.23  0.34 to  0.11 0.00 0.15 0.02–0.27 0.02  0.09  0.30–0.12 0.38
Recent cancer diagnosis in a relative  0.09  0.55–0.38 0.71 0.01  0.41–0.44 0.96 0.06  0.69–0.82 0.86
Recent death of a relative  0.17  0.65–0.31 0.49 0.13  0.57–0.30 0.54 0.40  0.45–1.25 0.36
Anxiety 0.02 0.00–0.04 0.02 0.00  0.02–0.02 0.99  0.02  0.05–0.02 0.32
Oophorectomy 0.51  0.03–1.05 0.07 0.00  0.51–0.50 0.99 0.07  0.78–0.91 0.88
Received gene test result  0.17  0.78–0.45 0.59  0.10  0.66–0.45 0.71 0.50  0.47–1.48 0.31
Family History Category 2 0.31  0.15–0.77 0.19 0.36  0.06–0.78 0.09 2.98 2.19–3.79 0.00
Family History Category 3 0.30  0.19–0.79 0.23 0.74 0.29–1.19 0.00 3.96 3.13–4.80 0.00
Mutation carrier 0.02  0.67–0.72 0.95 1.18 0.52–1.85 0.00 4.29 3.19–5.39 0.00
Estimate of population risk — — — — — — 0.00  0.02–0.02 0.95
Constant  0.06 1.85–1.72 0.94  3.27  5.08 to  1.46 0.00  3.22  6.32–0.12 0.04
CI¼confidence interval; RR¼relative risk.
aUnstandardised b-coefficient.
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smuch (as it is usually correct in the higher family history categories),
then the data in this study showed a ceiling effect, and women have
in fact correctly understood the degree to which their family history
increases their risk. However, if the women provide lower estimates
of their absolute risk, then they have not understood the extent to
which their family history increases their own risk.
For women in the lowest family history category (those
at population risk), the estimate of their absolute risk was
generally far too high, but once their estimate of the population
risk (also far too high) was taken into account, their comparative
risk estimate was generally correct. That is, these women have
placed their anchor point too high but it seems that they
understood that they are at the same risk as other women in the
general population.
Participants in the study were drawn from a cohort of Ashkenazi
Jewish women participating in a study of the BRCA1 and BRCA2
genes. It is not known to what extent these findings may be
applicable to other groups. The principles and questions used in
this study could easily be applied to other populations to
determine whether findings in this study apply to those groups.
CONCLUSION
In this study of Ashkenazi Jewish women we have shown that
population risk is substantially overestimated. Although significant
predictors were found, we were unable to explain most of the
variation in the population risk estimate, and we suggest that it
may be simply an anchor point upon which women base their other
risk estimates. We also found that absolute risk estimates are
substantially overestimated by women at population risk, but that
this overestimation decreases with increasing family history.
Related to this, estimated comparative risk was correct for about
half of women at population risk, but substantial underestimation
occurs with increasing family history.
These findings suggest that women at population risk generally
understand their risk, and may be able to provide a better estimate
of their absolute risk with better education about the population
risk. These findings also suggest that women with a stronger family
history understand that their risk is higher due to their family
cancer history, but may not understand the full extent to which
their risk is higher due to this risk factor. However, the possibility
that the underestimation of comparative risk in these women was
due to a ceiling effect should be examined in further studies.
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